// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Video observed treatment for tuberculosis patients in Belarus.

Alena Skrahina - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

IPF exacerbations: Role of Respiratory tract infections

Shoaib Malik - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Albert

Four metre gait speed (4MGS) predicts mortality and hospitalisation in IPF

Claire M. Nolan - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Association of height growth in puberty with maximally attained lung function

Osama Mahmoud - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Validity of COPD diagnosis in Bronchiectasis patients: data from the EMBARC registry

Maria Aurora Pinto Mendes - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials

David Halpin - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

salmeterol + fluticasone

The effect of pulmonary rehabilitation on health-related quality of life in patients with pulmonary sarcoidosis

Katerina Neumannova - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Sarcoidosis

N/A

Synchronous primary lung cancers;a clinical challenge in modern thoracic oncology

Georgia Hardavella - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Impact of treprostinil on dynamin-related protein 1 (DRP1) and mitochondrial fragmentation in pulmonary arterial hypertension (PAH).

Jeries Abu-Hanna - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

Treprostinil

Improvement of small airway deposition of corticosteroids by smart nebulisation

Bernhard Mllinger - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Symptomatic GORD in difficult asthma is associated with worse asthma control and related comorbidities: Findings from WATCH

Yvette Thirlwall - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

In the era of personalised medicine, is pleural fluid cytology sufficient for oncological treatment?

Rachel Mercer - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

Cleaning products and respiratory health effects in professional cleaners: A systematic review

Olga Archangelidi - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Accuracy of high-speed video microscopy to diagnose primary ciliary dyskinesia

Bruna Rubbo - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary ciliary dyskinesia

N/A

A double-blind, randomized, sham-controlled study of Targeted Lung Denervation in patients with moderate to severe COPD

Dirk-Jan Slebos - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Influenza

N/A

Body mass index and lung function: A two-step epigenetic Mendelian randomization study

Andre F.S. Amaral - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Distinct metabolic alterations in airway macrophages during pulmonary fibrosis

P Ogger - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pulmonary fibrosis

Bleomycin

Is attendance and completion of a pulmonary rehabilitation programme associated with patient activation?

Shauna Sheridan - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Exacerbation frequency and eosinophil levels for GOLD C and D COPD patients currently prescribed multiple inhaler triple therapy (MITT)

Victoria Benson - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Unusual case of bilateral hemotympanum after endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)

Usman Maqsood - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic obstructive pulmonary disease

Alfentanil hydrochloride

Copyright © 2026. QuantiNova All rights reserved